Nav: Home

Stereochemistry: Self-amplifying selectivity

December 05, 2016

Ludwig-Maximilians-Universitaet (LMU) in Munich chemist Oliver Trapp has designed and synthesized a catalyst which flexibly molds the handedness of the reaction products with which it interacts.

Many chemical compounds contain so-called chiral centers to which functional groups can be attached in either of two orientations. This gives rise to two different forms of the product which are mirror images of one another: Their spatial conformations are related to each other in the same way as right and left hands. Moreover, such configurational pairs - generally referred to as enantiomers - may exhibit different properties. For this reason, synthetic chemists are often faced with the problem of ensuring that the final product has the correct enantiomeric form. Oliver Trapp (Professor of Organic Chemistry at LMU since September 2016) and Golo Storch (a member of his previous research group at Heidelberg University, and currently at Yale University) now report the development of a catalyst that dynamically adapts to the stereochemistry of the compounds with which it interacts, and can progressively select for the desired enantiomer. The work is described in a paper which has just appeared in the journal Nature Chemistry.

Their system is based on a pair of molecular backbones that are known to interact with one another with enantiomeric selectivity. One of these serves as the carrier of the desired product while the other is equipped with a metal catalyst and flexible binding sites that recognize the product. The catalyst interacts transiently and repeatedly with the products of its own action, and can swiftly adjust the configuration of its binding sites. "We ourselves were surprised at how rapidly the catalyst adapts," Trapp says. These interactions effectively modify the structure of the catalyst in such a way that its stereoselectivity is enhanced. Once the catalyst has recognized the desired enantiomer, its selective efficiency improves with every further catalytic cycle. The final result of this self-amplifying action is that the end-products all have the same chiral structure.

This dynamic adaptability is of great interest in the context of the drug industry's never-ending search for biologically active compounds. Not only that, it may throw new light on how stereoselective chemical reactions operate in biological systems, where one normally finds only one chiral form of any given compound. "The world in which we live is monochiral," says Trapp. "Researchers have not yet found a convincing explanation for this. But it is conceivable that the functional principle of supermolecular interaction which we have exploited was also crucial for the origin of life."
-end-


Ludwig-Maximilians-Universität München

Related Binding Sites Articles:

Understanding differences in streptavidin-biotin binding
Beckman research scientist Rafael C. Bernardi recently published a paper that uses computational tools to explain the mechanism of how streptavidin and biotin binding is affected by streptavidin's tethering.
Cancer cells spread using a copper-binding protein
Researchers at Chalmers University of Technology, Sweden, have shown that the Atox1 protein, found in breast cancer cells, participates in the process by which cancer cells metastasise.
Using a molecular motor to switch the preference of anion-binding catalysts
Many organic molecules are chiral, which means that they are non-superimposable on their mirror image.
Self-assembling system uses magnets to mimic specific binding in DNA
A team led by Cornell University physics professors Itai Cohen and Paul McEuen is using the binding power of magnets to design self-assembling systems that potentially can be created in nanoscale form.
Chitin-binding proteins override host plant's resistance to fungal infection
A recent Molecular Plant-Microbe Interactions article studies chitin-binding proteins from a soilborne fungus (Verticillium nonalfalfae) that causes vascular wilt in plants.
Team plucks needle from genomic haystack, finding essential transcription factor binding sites
Using CRISPR/Cas9 knockout screens, a multi-institutional research team systematically interrogated the essentiality of more than 10,000 forkhead box protein A1 (FOXA1) and CTCF binding sites in breast and prostate cancer cells, finding that essential FOXA1 binding sites act as enhancers to orchestrate the expression of nearby essential genes.
Scientists recalculate the optimum binding energy for heterogeneous catalysis
In a discovery that could lead to the development of novel catalysts that do not rely on expensive rare metals, scientists from the RIKEN Center for Sustainable Resource Science have shown that the optimal binding energy can deviate from traditional calculations, which are based on equilibrium thermodynamics, at high reaction rates.
Research into Parkinson's disease: Binding-protein prevents fibril proliferation
Several neurodegenerative diseases such as Parkinson's are closely linked to the aggregation of a specific protein, α-synuclein.
NTU Singapore scientists uncover binding secret behind protein 'superglue'
Scientists from Nanyang Technological University, Singapore have pinpointed how a special class of plant-derived enzymes, known as peptide ligases, work to join proteins together -- an important process in the development of drugs, for example in specifically attaching a chemotherapy drug to an antibody that recognizes tumor markers to target cancer cells.
Diving into the details: A lipid-binding pocket is a target for new cancer therapies
Cell growth is tightly controlled; however, cancer cells overcome the normal growth controls and proliferate uncontrollably.
More Binding Sites News and Binding Sites Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.